Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIVER AKI albumin versus saline trial in decompensated cirrhosis with acute kidney injury
2025-521457-16-00Phase 4Authorised
- Sponsor
- IDIBAPS
- Start
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Cirrhosis comparing Human serum albumin with 0.9% sodium chloride (2 arms). Primary endpoint: AKI resolution. Planned start Oct 2025; status: authorised.
02
Drugs
albumin (human)sodium chloride
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on 2025-521457-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521457-16-00.